INTRODUCTION
The mainstream perspective of sudden infant death syndrome (SIDS) is that of a multi-factorial disorder infl uenced by developmental, environmental and biological risk factors. 1 The environmental risk factors for SIDS parallel those for serious infections 2 and a signifi cant number of SIDS cases present with symptoms of infectious diseases shortly before death. 3 Infections are very common in the fi rst year of life, more so than the incidence of SIDS; 4 thus, if infection plays a role in the cause of SIDS, a biological risk or predisposing factor might be involved. The hypothesis that SIDS pathogenesis may be via an inappropriate immune response to infection has prompted numerous cytokine gene polymorphism association studies 5 -9 including an investigation into interleukin 1β C-511T and interleukin 1 (IL-1) receptor antagonist ( IL-1RN ) T+2018C single nucleotide polymorphisms. 10 IL-1 is a cytokine responsible for causing rapid vasodilation in septic shock which can be induced by Staphylococcus aureus toxins 11 which are suspected to play a role in SIDS. 12 13 In previously published work we conducted a pilot study investigating the IL-1RN 89 bp variable number of tandem repeats (VNTR) polymorphism genotype, in cases of unexplained sudden unexpected death in infancy (uSUDI). This group consisted of SIDS infants from South Australia matching the 1989 defi nition for SIDS 14 and 10 infants from Victoria constituting one category 1a and seven category 2 SIDS infants meeting the 2004 defi nitions for SIDS 15 and two unascertained cases 16 An association was found between the homozygous 2 allele (A2) and uSUDI (p=0.007) where carriage of the 2/2 genotype gave a 4.85 times increased risk of uSUDI compared with the predominant 1/1 genotype. Unfortunately, gestational age data were not available for this cohort and as preterm birth is a risk factor for SIDS it could be over-represented in the uSUDI cohort compared with the control group. The live infant control group had an excess of males (62%) compared with the uSUDI group (54%) and was collected prospectively during a different decade from the majority of the uSUDI cases, during which genotypes could be infl uenced by different selective pressures. The possible association between IL-1RN A2 and uSUDI needed to be investigated further in a larger cohort with greater statistical power and ideally matched (for date of birth, sex and birth weight) controls. This study was designed to investigate whether the carriage of 2/2 genotype is associated with SIDS when cases are matched to controls for preterm birth and gender, and to analyse for potential new associations in a larger cohort.
MATERIALS AND METHODS

Selection criteria
The South Australian Neonatal Screening Laboratory assisted us in identifying the newborn screening cards (NSCs) of 120 confi rmed SIDS cases and 240 matched healthy infant controls. All SIDS infants met the criteria specifi c to the defi nition for SIDS at their time of death (either the 1969, 17 Two control infants were matched to each SIDS infant by date of birth, sex, birth weight (±500 g), gestational age, time lapsed from birth to NSC sampling and ethnicity. Time lapsed from birth to NSC sampling was matched for future investigations where age at the time of sampling might be a confounding factor. They were checked against the pregnancy outcomes database to ensure they were suitably matched, did not have any birth defects notifi ed and had survived at least the neonatal period (the fi rst 28 days). The NSCs of 118 SIDS and 233 control infants were located and sampled (changes over time in the accession and storage of NSCs rendered some of the older samples inaccessible). Eighty-four per cent of NSCs (SIDS cases and controls) were from infants born between 1987 and 1994 and 16% born between 1995 and 2006. Twenty-nine SIDS infants were included in both the previous pilot study 16 and the present cohort (ie, their NSCs could be identifi ed and located). Birth weight and gestational age are closely correlated; birth weight was chosen for subanalysis because data were available for all infants (six controls had no gestational age recorded).
Sample preparation
A single 1.2 mm diameter punch biopsy was taken from each dried blood sample with 20 punches of blank card in between to prevent carry-over contamination. Nucleic acids were released from the punches by treating with a cell lysis and solution containing 50% w/v Chelex-100 (Biorad, Hercules, California, USA), 2% w/v SDS, 0.1 M Tris and 5 mM EDTA . Chelex-100 binds to polar cellular components from the lysed cells leaving the nucleic acids free in the supernatant solution. Then 1 mg of proteinase K was added, and the solution was incubated at 60°C for 30 min to digest cellular proteins (Roche, Mannheim, Germany) and then heated to 95°C for 30 min to denature the DNA. Chelex-100 was pelleted by centrifugation, the supernatant was diluted 10-fold and 2 μl was used in each PCR.
PCR amplifi cation
IL-1RN was amplifi ed using the primer pair published by Tarlow et al 18 with the following cycling conditions: 95°C 2 min, 38 cycles of 95°C 30 s, 59°C 30 s, 72°C 1 min and a fi nal extension of 72°C 3 min on a Bio-Rad IQ5 cycler (Biorad). IL-1RN genotype was determined by the amplicon size (VNTR) as described by Tarlow et al 18 The amplicon sizes were: allele 1 (A1) 410 bp; A2 240 bp; A3 500 bp; A4 325 bp and A5 595 bp. Each PCR consisted of 0.05 μM MgCl 2 , 1× Colourless GoTaq Flexi Buffer, 0.025 μM dNTP mix, 0.05 μM each of the primer pair and 0.5 units GoTaq DNA Polymerase (Promega, Madison Wisconsin, USA), 2 μl of extracted DNA and PCR-grade water to a total volume of 12.5 μl. Amplifi cation products were visualised on a 2% agarose gel stained with GelRed (BioTium, Hayward, California, USA) alongside a pUC19/ Hpa II DNA molecular weight marker (Geneworks, Thebarton, South Australia). Homozygous 1/1 and 2/2 controls for each genotype were sourced from the study cohort and confi rmed by sequencing the amplifi cation products (IMVS Sequencing Centre, Adelaide, South Australia).
Statistics
The statistical power for a study with 118 cases and 233 control subjects, when prior data indicate that the probability of A2 among controls is 0.2 based upon the allele frequencies for cases and controls observed in the pilot study, 16 was calculated using PS Power and Sample Size Calculations (V.3.0, January 2009). If the true probability of A2 exposure among cases is 0.37, we will be able to reject the null hypothesis that the exposure rates for cases and controls are equal with a probability (power) of 92.2%. The type I error probability associated with this test of the null hypothesis is 0.05. Yates corrected probability test using the 2 × 2 contingency table software (Statcalc, Epiinfo V.6) was applied to evaluate this null hypothesis. SIDS genotypes were analysed against those of live control infants by comparing homozygous and heterozygous variant allele carriage with the 1/1 genotype using χ 2 and Fisher's exact tests where appropriate. To compare the controlled variables for the SIDS and control groups, χ 2 was used to test for signifi cant differences in categorical variables (ethnicity, gender and month of birth) and Mann-Whitney U test for continuous variables not expected to follow a normal distribution (gestational age and birth weight).
Ethical considerations
Approval was granted by the Human Research Ethics Committee of the Children Youth Women's Health Service, North Adelaide, to test NSCs from SIDS and control infants using samples which were 're-identifi able', marked with only a laboratory number linked to data held by an external party (The South Australian Pregnancy Outcomes Statistics Unit). The investigators were blind to the identities of the infants, and their SIDS/control status for the duration of this study.
RESULTS
IL-1RN genotypes in SIDS and control infants
IL-1RN VNTR genotype and allele frequencies for SIDS and control infants are shown in tables 2 and 3 , respectively. Not all samples gave a valid result due to the presence of PCR inhibitors in blood, or possible DNA degradation after prolonged NSC storage. Table 1 shows the distribution of controlled variables for the successfully genotyped SIDS and control cohorts. One hundred and thirteen SIDS infants and 218 controls gave a valid IL-1RN genotype result ( table 2 ). The statistical power of the study to detect the expected difference in A2 carriage based on previous data 16 
IL-1RN genotypes in SIDS and control infants born 1987-1994
Genotypes of 94 SIDS infants (29 were also in the pilot study) and 185 controls born in the period 1987-1994 were compared separately for associations as these infants died when SIDS displayed a particularly high incidence. Of the SIDS infants 18.1% carried the 2/2 genotype compared with only 9.1% of the control infants ( table 2 ). Compared against carriage of the wild-type, this difference was signifi cant (p=0.025, OR=2.48, 95% CI 1.09 to 5.59).
DISCUSSION
IL-1RN genotypes in SIDS and control infants
The aim of this study was to investigate if carriage of 2/2 IL-1RN genotype is associated with SIDS when compared with controls that have been matched for preterm birth and gender. On comparing the 2/2 and 1/1 genotype frequencies of 113 SIDS infants and 218 controls we found no signifi cant differences. This was surprising given the results of our previous study of a smaller cohort, in which the 2/2 genotype was signifi cantly associated with unexplained infant deaths which were predominantly SIDS. 16 The 1/2 genotype was signifi cantly more frequent in males compared with females. This was an unexpected fi nding which might be signifi cant in relation to the increased risk of SIDS seen in males. However, since we saw no increase in the 2/2 'risk' genotype in males, it is diffi cult to explain why the heterozygous combination (which should have intermediate IL-1ra expression) is more common. No signifi cant difference in genotype frequencies was observed between low birthweight (≤2500 g) and normal birthweight (>2500 g) infants. A3 carriage was found to be signifi cantly more common in SIDS infants compared with control infants (p=0.04). However, as the frequency of this allele is relatively less common, the small numbers observed must be analysed with caution. This association could have gone undetected in the smaller cohort examined in the pilot study due to the low statistical power. The biological effects of IL1-RN A3, and whether it alters IL-1β production is currently unknown, but it has been implicated in recurrent spontaneous abortion, a condition believed to be promoted by a pro-infl ammatory state. 19 The IL-1RN A3 variant has been reported to lack an in-frame coding segment, as compared to variant 2, and the resulting isoform lacks an internal region ( NCBI Reference Sequence: NM_000577.3 data). Theoretically, this 'less-functional' form of IL-1ra could be less effi cient in binding IL-1 receptors and might not exert immune control to the extent of the wild-type. Thus the association of A3 with SIDS might refl ect unchecked IL-1β levels and subsequent progression to a severe pro-infl ammatory response and possible death.
IL-1RN genotypes in SIDS and control infants born 1987-1994
In a previous pilot study we observed a signifi cant association between IL-1RN A2 and uSUDI cases, which were predominantly SIDS infants who died in the early 1990s. 16 On examination of infants born in the period 1987-1994 in the present cohort, we found a signifi cant association between SIDS and A2. These results suggest that the higher frequency of A2 observed in the pilot study could possibly be involved in SIDS from this time. However, as the number of cases decrease in subanalyses these results should be interpreted with caution to avoid type I error.
In the current study (including all birth years) we found the 1/2 genotype was signifi cantly more common in males compared with females. This gender-specifi c difference was unlikely to have accounted for the higher frequency of A2 in the SIDS/uSUDI group in the pilot study as the live control group had more males than the uSUDI group (54% vs 62%) and so theoretically should have over-represented A2.
There might be an epidemiological factor that could help explain why SIDS in the higher incidence period 1987-1994 had a different IL-1RN genotype distribution compared with latter cases. The SIDS rate in South Australia rose through the 1970s and early 1980s to a peak incidence of 2.4 per 1000 live births in 1986, and then began to decrease. 20 This parallels the wave-like pattern of incidence typical of an infectious disease. 21 22 We propose that a major contributing factor to these deaths was infection, causing a high mortality in infants whose risk was potentiated by an IL-1RN 2/2 genotype and were more susceptible to a sustained proinfl ammatory response. The decrease in babies being put to sleep in the prone position is a well-recognised preventive measure, which in some regions led to a decrease in SIDS deaths in the prone position. 23 Prone sleeping has been shown to promote the accumulation of staphylococci in the nasopharynx, a common fi nding in SIDS. 24 15 .9% in the present study, and 7% controls with 2/2 in Ferrante's study versus 9.6% in the present study. In Norway SIDS exhibited a similar decline in incidence to that in Australia, which began in the early 1990s. Accordingly if Ferrante et al had analysed their cases born until 1995 separately, a similar association with A2 might have been found. In a study by Moscovis et al a single nucleotide polymorphism in IL-1RN (T+2018C) was found not to be differently distributed between SIDS infants and controls 10 , where the SIDS infants died between 1995 and 1997. 13 Similarly, if this experiment was replicated in our cohort of earlier SIDS infants, born prior to 1995, a higher frequency of IL-1RN (T+2018C) might be observed, in parallel with our fi ndings of higher IL-1RN VNTR A2 in these infants. Such a fi nding would support the involvement of IL-1RN in SIDS.
CONCLUSION
The human immune system is extremely complex in nature and is controlled by a vast array of genes. While the list of candidate genes for polymorphism analysis in SIDS appears endless, those genes involved in immunoregulatory processes deserve special attention as they have a powerful affect on the homeostatic balance. The higher prevalence of IL-1RN A2, which predisposes to poor outcomes from infection, in earlier SIDS cases suggests that the high incidence during this period could point to an underlying infectious aetiology. An association of the IL-1RN low frequency A3 with SIDS was also observed; however, the signifi cance of this is unknown in the absence of functionality studies for this variant isoform.
